首页 | 本学科首页   官方微博 | 高级检索  
     


Large-Scale,Prospective Observational Study of Regorafenib in Japanese Patients with Metastatic Colorectal Cancer in a Real-World Clinical Setting
Authors:Kensei Yamaguchi  Yoshito Komatsu  Taroh Satoh  Hiroyuki Uetake  Takayuki Yoshino  Toshirou Nishida  Naoya Yamazaki  Hajime Takikawa  Takashi Morimoto  Masayuki Chosa  Toshiyuki Sunaya  Yoko Hamada  Kei Muro  Kenichi Sugihara
Affiliation:1. Department of Gastroenterological Chemotherapy, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan;2. Department of Cancer Chemotherapy, Hokkaido University Hospital Cancer Center, Sapporo, Japan;3. Department of Frontier Science for Cancer and Chemotherapy, Osaka University Graduate School of Medicine, Suita, Japan;4. Department of Specialized Surgeries, Tokyo Medical and Dental University, Tokyo, Japan;5. Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan;6. National Cancer Center Hospital, Tokyo, Japan;7. Department of Dermatologic Oncology, National Cancer Center Hospital, Tokyo, Japan;8. Department of Medicine, Teikyo University School of Medicine, Tokyo, Japan;9. Medical Affairs Oncology and Hematology, Bayer Yakuhin Ltd., Osaka, Japan;10. Pharmacovigilance & Medical Governance PMS, Bayer Yakuhin Ltd., Osaka, Japan;11. Clinical Statistics, Bayer Yakuhin Ltd., Osaka, Japan;12. Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan;13. Tokyo Medical and Dental University, Tokyo, Japan
Abstract:
Keywords:Regorafenib  Metastatic colorectal cancer  Safety  Observational study  Postmarketing
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号